Stock futures were falling early Wednesday after gaining in the previous session as the U.S. trade war started to hit economic data, an ominous sign that the real-world impact of President Donald Trump’s tariffs will soon be felt.

Global stocks mostly rose despite fresh signs of a tariff hit to corporate earnings, while Wall Street cheered President Donald Trump's moves to soften the levies hitting automakers.

Trump makes a momentous political comeback, breaking through the "blue wall" to win 312 electoral votes. Trump becomes only the second US president in history to be elected to non-consecutive terms, following Grover Cleveland (the 22nd and 24th US president).

U.S. stocks closed out Donald Trump’s first 100 days back in the Oval Office on a sour note, with the president’s trade policies taking the blame for derailing a thriving market and stoking fears the world’s largest economy could slip toward recession.

Health and wellness company, which sold alternatives to weight-loss drugs like Wegovy, is now collaborating with Wegovy-maker Novo Nordisk.

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.Hims & Hers users will have access to Novo Nordisk's Wegovy starting this week,